Screener
Pacira BioSciences, Inc. PCRX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $4.65M+196% | $2.92M-39.4% | $1.64M— | $5.43M+104% | -$4.85M-126% | ||
| $21.3M-22.1% | $21.33M+0.8% | $21.34M+0.5% | $21.19M+4.6% | $27.32M+44.8% | ||
| $14.96M-3.3% | $13.54M-7.0% | $13.5M+10.1% | $13.98M+5.7% | $15.47M+23.5% | ||
| $57.46M+378% | $25.68M-27.6% | $43.69M+31.9% | $60.83M+12.8% | $12.01M-77.4% | ||
| $1.34M-50.5% | $2.72M-68.1% | $218K-89.7% | $3.87M-5.4% | $2.7M+69.6% | ||
| —— | $335K-98.0% | —— | —— | —— | ||
| $11.76M-81.1% | $19.44M+176% | $19.33M+5,354% | $43.61M+184% | $62.16M+509% | ||
| —— | $50.05M— | $48.25M+672% | $50.04M+701% | $50.04M+701% | ||
| $5M— | $5M— | $5M— | $5M— | $0— | ||
| -$7.65M+86.7% | -$59.4M-1,884% | -$51.65M— | -$257.48M— | -$57.51M-330% | ||
| $61.57M+265% | -$14.24M-308% | $0— | -$152.9M— | $16.87M-73.2% | ||
| $56.12M+503% | $22.96M-14.7% | $43.47M+40.2% | $56.96M+14.3% | $9.32M-82.0% |
FAQ
- How much cash does Pacira BioSciences, Inc. generate?
- Pacira BioSciences, Inc. (PCRX) generated $187.7M in operating cash flow over the trailing twelve months.
- What is Pacira BioSciences, Inc.'s free cash flow?
- After $8.1M of capital expenditures, Pacira BioSciences, Inc.'s free cash flow was $179.5M over the trailing twelve months, up 53.3% year over year.
- Where does Pacira BioSciences, Inc.'s cash flow data come from?
- Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
